Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Cronos Group Inc. (CRON : NSDQ)

• Company Description    Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada. Number of Employees: 459

• Price / Volume Information    Yesterday's Closing Price: $2.63 Daily Weekly Monthly 20 Day Moving Average: 4,106,280 shares Shares Outstanding: 382.39 (millions) Market Capitalization: $1,005.70 (millions) Beta: 0.70 52 Week High: $3.43 52 Week Low: $1.60 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 5.62% 5.80% 12 Week -2.95% -4.52% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4491 CONCESSION RD 12 - STAYNER,A6 L0M 1S0 CAN ph: 416-504-0004 fax: - investor.relations@thecronosgroup.com http://www.thecronosgroup.com

• General Corporate Information    Officers Michael Gorenstein - Chairman; President and Chief Executive Officer James Holm - Chief Financial Officer Jimmy McGinness - Vice President; Controller Elizabeth Seegar - Director Dominik Meier - Director Peer Information Cronos Group Inc. (GSAC) Cronos Group Inc. (CASI) Cronos Group Inc. (ALCD.) Cronos Group Inc. (OMNN) Cronos Group Inc. (CGPI.) Cronos Group Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 22717L101 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/26/26 Share - Related Items Shares Outstanding: 382.39 Most Recent Split Date: (:1) Beta: 0.70 Market Capitalization: $1,005.70 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.08 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/26/26

• Fundamental Ratios P/E Current FY Estimate: 32.88 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.89 Price/Cash Flow: 5,652.02 Price / Sales: 7.60 EPS Growth vs. Year Ago Period: 450.00% vs. Previous Quarter: 170.00% Sales Growth vs. Year Ago Period: 6.06% vs. Previous Quarter: 8.62% ROE 12/31/25 - - 09/30/25 - -1.12 06/30/25 - -3.78 ROA 12/31/25 - - 09/30/25 - -1.07 06/30/25 - -3.62 Current Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 24.65 Quick Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 23.53 Operating Margin 12/31/25 - - 09/30/25 - -7.10 06/30/25 - -32.53 Net Margin 12/31/25 - - 09/30/25 - 27.27 06/30/25 - 14.19 Pre-Tax Margin 12/31/25 - - 09/30/25 - 5.77 06/30/25 - 14.45 Book Value 12/31/25 - - 09/30/25 - - 06/30/25 - 2.94 Inventory Turnover 12/31/25 - - 09/30/25 - 2.07 06/30/25 - 2.23 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - 0.11

Powered by Zacks Investment Research ©